VHT (ASX) Ann: FY2018 Guidance Exceeded

Originally posted by zdog13 ↑

Agree - the last quarter was by far the strongest for the year.

This shows that the sales team are converting more and more leads.

3% if women in the US is large in in number but small in %ge.

If we extrapolate TCV from m $11M at 3%, then 30% will be $110M - how long until this will this happen, what does that do to the MCAP?

I see This company having some good upside ahead, however:

1) cash burn is concerning - they will need more money soon. Is this a share placement or will the CR from existing shareholders? I would prefer the latter.
2) they propose the be profitable in 2019, however they have already noted that the don’t see that they will pay a divided but look for other market opportunities - I don’t see a problem with this
3) take over potential - I see this product being very specific and one that would easily compliment technology manufacturers - do I see a TO being a likely hood? Not really, the founders have ~35% and they are by far the largest block. I see that they want to make a difference since they will continue until their work is done!

Thanks s is a great of news/socially responsible company. As the company becomes profitable, investment funds I believe will jump on board, however we will need to know the answer to Q2 above first.

Expand

Very well said. VHT should be played for long haul. Slowly but steady it is started to penetrate the US market. Sales maybe take longer time than other services/products but once it's done it's very sticky. Unlike other bio comps in which they spend money on R&D, trial tests without achieving much revenue or cash inflows, I'm very happy to see that VHT has achieved decent revenue in such a short period of time. And yes, cash burn is a bit concern but that cash is spend on Sale & Marketing which result in revenue so not much to worry on that either. My most concern here is a CR. Given at end of 2017 they had roughly 7M cash on hand and they consume approximately 2M cash per quarter, so I expect a CR will probably be around mid year. I hope management can do a CR at a good price, unlike, last time they did a 15-20% discount. Other than that, everything is OK with me and I think the company is on the right track, right direction. More importantly, management made up of 35% of the register, a good indication of management's interests are aligned with shareholders.

Another point to note that in last 4c report they said that VHT expects a decrease in cash outflow but a significant increase in cash inflow in Q4. So, I hope they will have a good 4c at end of this month.